Atlas Venture Life Science Advisors, LLC Kymera Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $799 Million
- Q1 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 5,377,362 shares of KYMR stock, worth $161 Million. This represents 27.05% of its overall portfolio holdings.
Number of Shares
5,377,362
Previous 5,858,262
8.21%
Holding current value
$161 Million
Previous $149 Million
44.93%
% of portfolio
27.05%
Previous 23.45%
Shares
4 transactions
Others Institutions Holding KYMR
# of Institutions
164Shares Held
63.1MCall Options Held
39.7KPut Options Held
9.7K-
Price T Rowe Associates Inc Baltimore, MD6.33MShares$189 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$179 Million3.05% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$154 Million6.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$142 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$128 Million0.03% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.63B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...